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Regine Fricke1, Olaf Bastert1, Verena Gotter1*, Nico Brons2, Johan Kamp2 and Hans-Joachim Selbitz1Abstract
Oedema disease is one of the major diseases in pigs during the nursery period. It is caused by Shigatoxin 2e
producing strains of Escherichia coli. In order to combat the disease, the metaphylactic use of colistin sulphate and
zinc oxide is widely spread. Additionally, special feeding regimens such as the reduction of the amount of crude
protein and the increase of the amount of crude fibre are applied. The goal of this study was to test the efficacy
of a vaccine against Oedema disease caused by Shigatoxin 2e in a field trial on a farm with a history of Oedema
disease in nursery pigs.
The study was carried out on a Dutch farm with 600 sows and a one-week farrowing rhythm and lasted for the
time of one year. During this time all piglets were vaccinated with 1 ml ECOPORC SHIGA at the average age of
4 days. The parameters Overall mortality, use of antimicrobials in general, calculated as defined daily dose per
animal, use of colistin sulphate and the weight gain were evaluated for all nursery pigs and compared to historical
data of animals from the same period of time directly prior to the study serving as a historical control group.
The previous mortality in the nursery of 7.7% was significantly reduced to 1.3% after vaccination. The metaphylactic
use of colistin sulphate during the nursery period was stopped during the study because no deaths due to
Oedema disease had occurred anymore after beginning of vaccination. The defined daily dose per animal per
month was significantly reduced from a mean of 1.050 in the year 2012 to a mean of 0.215 in the year 2013.
The defined daily dose per animal per year was therefore relevantly reduced from 12.6 in 2012 to 2.6 in 2013.
These results show that on this farm Oedema disease can not only be controlled successfully by vaccination but
also that vaccination can significantly reduce the use of antimicrobials in the nursery period.
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Oedema disease (ED) is one of the most costly diseases
in pig production today. It is caused by Shigatoxin 2e
(Stx2e) producing strains of Escherichia coli (STEC),
which are sometimes also called Verotoxin producing
Escherichia coli (VTEC) [1]. Those STEC strains that
cause Oedema disease are called (EDEC). For many
years, the only way to fight the disease was by a combin-
ation of the metaphylactic use of antimicrobials such as
colistin sulphate and/or zinc oxide and diverse manage-
ment practices. However, the widespread use of antimi-
crobials in livestock production is increasingly being* Correspondence: verena.gotter@idt-biologika.de
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creativecommons.org/publicdomain/zero/1.0/questioned by the public, also because the use of antimi-
crobials [2] and zinc oxide increases resistance in E. coli
[3]. While in general the resistance of E. coli to colistin
is low (<1%), in some cases in Belgium it reached 9.5%
in sick pigs [2]. Therefore many governments in Europe
(for example Denmark, Germany and the Netherlands)
have passed legislation to reduce the use of antimicrobials.
In the Netherlands for example a benchmark system clas-
sifies farms into 3 different categories according to their
consumption of antimicrobials calculated as Defined Daily
Dose per year (DDD/y) on farm level. A classification into
a category with high antibiotic use leads to requirements
to reduce the use of antimicrobials [4].
Among the diverse management practices developed
to prevent the occurrence of ED, the most popular is toicle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Table 1 Overall mortality during nursery period
Group Overall mortality during
nursery period (%)
std dev N p-value




N = Number of months recorded.
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as this is implemented most easily [5]. The adjustment
mainly consists of reducing the amount of crude protein
in the diet from 210 g/kg to at least 180 g/kg while at
the same time increasing the amount of crude fibre from
30–50 g/kg to 60–65 g/kg. However this method alone
is often not enough to reduce the occurrence of ED and
antimicrobials still have to be used. Also it has been the-
orized that due to this type of feeding regimen, piglets
cannot gain the weight that their genetic potential would
offer [6].
Because the most common adhesion factor by which
EDEC bind to the enterocytes in the gut are the F18
fimbriae [1] geneticists have been trying to breed a F18-
resistant pig for some years [7]. This may be an effective
method to face the disease. Still most pigs though are
susceptible to F18 bearing E. coli.
Research groups around the world also used the Stx2e
itself as a focal point, primarily when looking for vac-
cines against ED. Recombinantly produced and by glu-
taraldehyde inactivated Stx2e was tested successfully in
field trials with pigs [8-13]. In each case mortality was
significantly lower in the vaccinated groups and partially
a significantly higher weight gain of the vaccinated ani-
mals could be shown. In laboratory trials recombinantly
produced and genetically inactivated Stx2e proved to
induce protection against an oral challenge with EDEC
[14] as well as an intravenous challenge with Stx2e [15].
Mortality and clinical signs of ED could be prevented
(0%) whereas the control animals became severely ill
(clinical signs 59% resp. 100%, mortality 35% resp. 33%).
Within laboratory trials for the recombinantly produced
and genetically inactivated vaccine ECOPORC SHIGA,
which was subject to this investigation, a significant pro-
tection against ED could be reached by vaccination [16].
Furthermore, the first field trials for the investigation of
safety and efficacy of ECOPORC SHIGA conducted onTable 2 Defined daily dose per animal (DDDanimal) per
month
Year Mean DDDanimal/month std dev N p-value
2012 1.050 0.479 12 <0.001
2013 0.215 0.217 12
N = Number of months recorded.farms affected by ED showed a significantly reduced
morbidity and mortality as well as a higher weight gain
for the vaccinated groups [17-19]. First large-scale longi-
tudinal studies with data from historical control groups
(HCG) within Germany [20-22] demonstrated that the
mortality due to ED as well as the use of colistin
sulphate were significantly reduced by vaccination with
ECOPORC SHIGA compared to a former period without
vaccination. Furthermore the weight gain was partially
increased in these studies [20]. Vaccination against the
disease seems a good alternative to antibiotic treatment,
because there is no risk of the development of resistances
in E. coli. Additionally, no special feeding is required.
The goal of this case study was to investigate the ability
of the commercially available vaccine ECOPORC SHIGA
of preventing ED on a Dutch farm with a high mortality
despite the use of colistin sulphate.
Case description
Case history
A 600 sow farm (breed: Topigs) in the Netherlands had
massive problems with ED in the nursery for over a year.
The farm is a single site facility with the farrowing barn
separated from the nursery. The farrowing rhythm is
one-week. Cross fostering is carried out until the age of
3 days but is kept to a minimum in order to avoid the
transmission of Streptococcus suis. Sows are vaccinated
against Parvovirus, Swine Erysipelas, Swine Influenza
and Colibacillosis in neonatal piglets. Weaning takes
place at an age of 25–26 days when the piglets weigh ap-
proximately 7.5 kg. After weaning, the piglets are trans-
ferred to the nursery. The nursery is run all in – all out
by compartment. Each age group has one compartment
and age groups are not mixed. Space and feeding require-
ments are met according to law. Water is supplied via
drinking nipples ad libitum. Nursery period ends at the
age of 11 – 11.5 weeks.
Within the period between 01.10.2011 and 30.09.2012
the mortality in the nursery was at 7.7% with a confirmed
mortality due to ED of 5.9%. Implemented measures like
low crude protein content of 160 g/kg in the feed as
well as the metaphylactic treatment of each weaned
week group with Colistin sulphate for the first 10 days
in nursery did not have any valuable impact on re-
duction of mortality. The diagnosis of ED had been
made based on the clinical examination of affected
piglets as well as the results of necropsies and micro-
biological analysis.
Study description
For the study a total of 17977 piglets were included
and vaccinated within the period from 02.10.2012 to
24.09.2013. Inclusion criteria were: a weight of more
than 800 grams, no clinical signs of an illness and the
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meet these criteria were not vaccinated and the number of
their respective ear tags was registered.
The piglets were vaccinated intramuscularly at the
base of the ear with a dose of one millilitre containing a
genetically modified and recombinantly produced Stx2e
(trade name ECOPORC SHIGA) at the average age of
four days. One dose of the vaccine (1 ml) contains ≥
3.2 × 106 ELISA units of recombinant Stx2e. The ad-
juvant is aluminium hydroxide. At the same time, the
piglets were ear tagged with different coloured tags
for each week group, as well as being injected with iron
(other side of the neck), the tails were docked and male
piglets were castrated.
Every day during the nursery period, the farmer
observed whether the piglets showed any clinical signs
of ED (Oedema of the eyelids and subcutis of the face;
nervous disorders like ataxia, paralysis of limbs, tonic-
clonic convulsions) and controlled the general appear-
ance of the piglets. When piglets showed signs of illness,
a clinical diagnosis was made whether or not the occur-
ring clinical symptoms were related to Oedema disease.
In case of losses for which the farmer was not able to
define a reason these piglets were sent for pathological
examination to examine the definite cause of death. This
included special investigations concerning the appear-
ance of Oedema disease, like PCR-testing of the isolated
E. coli strains regarding factors of pathogenicity and
histopathological examination of e.g. the brain. In order
to assure the presence of EDEC despite vaccination rec-
tal swabs were taken from vaccinated 7 weeks old ani-
mals by the herd attending veterinarian at the end of the
study. No changes were made regarding the content of
crude protein in the feed during the study in order to
maintain equality of the requirements for comparison.
Observed and compared data were the Overall mortal-
ity (expressed as the mean percentage of all dead piglets
during nursery period per weaned piglets on monthly
basis without regard to the reason of death), the meta-
phylactic use of colistin sulphate (defined as DDD animal
colistin sulphate/month) and the general use of antimicro-
bials (defined as Mean DDD animal/month) within the
period of one year prior to vaccination and one year with
vaccination. Additionally, the mean body weight at sale of
the total of pigs sold in the defined period was calculated
via software (Pigmanager) and compared to the previous
period with unvaccinated animals. The vaccination was
performed by the herd attending veterinarian. The obser-
vations and recording of the data were carried out by the
farmer, following training in the study protocol and was
supervised by the herd attending veterinarian. Statistical
analyses were performed by SPSS 15.0 for Windows (SPSS
Inc., Chicago, Illinois, USA). Analyses performed included
the Mann–Whitney-U-test.Ethical approval for this study was granted by our
company IDT, in line with requirements in Germany for
studies involving animals. The proper authorities in the
Netherlands were also notified prior to the start of the
study, and granted all required approvals.
Results
The mean Overall mortality of 7.7% prior to vaccination was
significantly reduced to 1.3% after vaccination (p < 0.001,
Mann–Whitney-U-test, two-tailed, asymptotic, see Table 1).
One piglet of the 11th vaccination group was classified
as “death due to Oedema disease”, but only by default.
When this piglet died, it was failed to be submitted to
necropsy and subsequent analysis. Thus because the
cause of death could not be determined, it was decided
to classify its death as due to Oedema disease. In two
animals clinical signs associated with ED (recumbence
with tonic-clonic convulsions) were observed after wean-
ing. After the piglets had died pathological examinations
as well as microbiological analyses were carried out.
Streptococcus suis was determined to be the cause of the
clinical signs. The analysis for Stx2e producing E. coli of
rectal swabs taken from 7 weeks old pigs at the end of
the study showed that the pathogen was still present on
the farm despite vaccination.
The metaphylactic use of colistin sulphate was stopped
after the 9th weaned group of vaccinated animals, because
until then no more deaths due to ED had occurred. It was
not implemented anymore during the study period. The de-
fined daily dose per animal (Mean DDD animal/month) for
all antimicrobials was reduced from a mean of 1.050 in the
year 2012 to a mean of 0.215 in the year 2013 (p < 0.001,
Mann–Whitney-U-test, two-tailed, asymptotic, see Table 2).
The sum of the Mean DDD animal/month for the year
2012 was 12.6. This was reduced to 2.6 for the year 2013.
The mean body weight of the sold groups was higher after
vaccination (25.252 kg vs. 25.618 kg respectively), but this
difference was not statistically significant.
Discussion and evaluation
In this study the effect of vaccination on the Overall
mortality was evaluated instead of the effect on mortality
only due to ED. This was due to the long period of time
of the study so that not every dead piglet could be sent
for necropsy in order to define the definite cause of
death. The assumption was made that if vaccination had
an effect on mortality due to ED then the Overall mor-
tality would be reduced significantly in comparison to
the Overall mortality within the same period of time
without vaccination. With the high mortality due to ED
on the farm and therefore ethical reasons a HCG was
chosen for the comparison of data instead of a rando-
mised control group (RCG). Although the choice of a
HCG has the potential to bias a study as different
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tifiable, considering that not just any period of time for
the historical comparison was chosen but exactly the
same time frame of 1 year. That time frame was set
exactly prior to the start of vaccination so that both
comparison groups were directly adjacent to each other.
Furthermore all animals from that previous period were
included for the HCG and not only a selected group of
animals. These measures were supposed to minimize
any impact of potential different conditions as far as
possible. In order to maintain comparability between the
HCG and the vaccinated study group regarding the in-
fluence of ED the implemented control measures like
dietary crude protein content and initially the treatment
with colistin sulphate were not changed. Thus the influ-
ence of vaccination only was supposed to be investi-
gated. As the use of antimicrobials was a parameter to
be compared between the groups and due to the fact
that after vaccination no deaths related to ED had oc-
curred anymore this control measure was ceased. On
the other hand though, the impact of a higher content of
crude protein in the diet could neither be evaluated on
the weight gain nor on the development of the disease
on farm level. Furthermore the presence of EDEC in
vaccinated animals was ensured by examination of rectal
swabs. This was expected and is due to the fact that the
vaccine induces protection against the Stx2e in the blood
but not against EDEC in the gut. In order to ensure a
consistent elicitation of the comparative parameters the
study data was collected in the same way as the histor-
ical data: The mortality had been recorded by the farmer
and additionally monitored by the herd attending veter-
inarian within the framework of the integrated veterinary
herd health care. Body weight at sale had been collected
routinely by suitable computer software (Pigmanager)
and the data on antibiotic use und thus the DDD had
been recorded by an official registration system.
The significant reduction of the Overall mortality by 6.4%
confirms not only the results from other investigations with
RCG’s in which ECOPORC SHIGA significantly reduced
the mortality on farms with ED [17-19] but also results from
other longitudinal trials with HCG’s and with high numbers
of animals [20-22]. The reduction resp. omission of colistin
sulphate led to a significant reduction of the DDD during
the nursery period so that the DDD on farm level was sig-
nificantly reduced and the farm was classified into a better
category of the Dutch benchmark system. The long lasting
reduction of antimicrobial use after implementation of the
vaccination could also be seen in other large-scale longitu-
dinal studies [20-22] and responds to the requirements of a
reduced use of antimicrobials in animal husbandry.
Due to the application of the vaccine at the age of four
days, it was easy for this farmer to integrate the measure
into his routine handling of the piglets. Since in modern pigproduction zoo-technical measures are often performed at
the age of three to seven days, the ability of vaccination
from the age of four days on makes it possible for such
farms to include this vaccination into their routine. Also the
application dose of one millilitre is small, an additional
advantage when dealing with young piglets.
Conclusions
From the results of this study it may be concluded that
the vaccination against Stx2e led to a significant reduc-
tion of mortality due to ED on this farm. Also it appears
likely that the implementation of the vaccination on this
farm has significantly reduced the used amount of anti-
microbials during the nursery period. These results con-
firm similar experiences made with this vaccine on other
farms with ED in other trials.
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